Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.
Landis MN, Arya M, Smith S, Draelos Z, Usdan L, Tarabar S, Pradhan V, Aggarwal S, Banfield C, Peeva E, Vincent MS, Sikirica V, Xenakis J, Beebe JS. Landis MN, et al. Among authors: sikirica v. Br J Dermatol. 2022 Dec;187(6):878-887. doi: 10.1111/bjd.21826. Epub 2022 Oct 23. Br J Dermatol. 2022. PMID: 35986699 Free PMC article. Clinical Trial.
Characterizing the relationships between patient-reported outcomes and clinician assessments of alopecia areata in a phase 2a randomized trial of ritlecitinib and brepocitinib.
Winnette R, Banerjee A, Sikirica V, Peeva E, Wyrwich K. Winnette R, et al. Among authors: sikirica v. J Eur Acad Dermatol Venereol. 2022 Apr;36(4):602-609. doi: 10.1111/jdv.17909. Epub 2022 Jan 25. J Eur Acad Dermatol Venereol. 2022. PMID: 35000236 Free PMC article. Clinical Trial.
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib.
Simpson EL, Wollenberg A, Bissonnette R, Silverberg JI, Papacharalambous J, Zhu L, Zhang W, Beebe JS, Vincent M, Peeva E, Bushmakin AG, Cappelleri JC, Chen L, Sikirica V, Xenakis J. Simpson EL, et al. Among authors: sikirica v. Dermatitis. 2021 Oct 1;32(1S):S53-S61. doi: 10.1097/DER.0000000000000725. Dermatitis. 2021. PMID: 33795561 Clinical Trial.
Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database.
Eichenfield LF, DiBonaventura M, Xenakis J, Lafeuille MH, Duh MS, Fakih I, Levenberg M, Cappelleri JC, Sikirica V. Eichenfield LF, et al. Among authors: sikirica v. Dermatol Ther (Heidelb). 2020 Aug;10(4):791-806. doi: 10.1007/s13555-020-00413-8. Epub 2020 Jun 30. Dermatol Ther (Heidelb). 2020. PMID: 32607738 Free PMC article.
Prevalence of Vitiligo Among Adults in the United States.
Gandhi K, Ezzedine K, Anastassopoulos KP, Patel R, Sikirica V, Daniel SR, Napatalung L, Yamaguchi Y, Baik R, Pandya AG. Gandhi K, et al. Among authors: sikirica v. JAMA Dermatol. 2022 Jan 1;158(1):43-50. doi: 10.1001/jamadermatol.2021.4724. JAMA Dermatol. 2022. PMID: 34787670 Free PMC article.
All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.
Mostaghimi A, Gandhi K, Done N, Ray M, Gao W, Carley C, Wang T, Swallow E, Sikirica V. Mostaghimi A, et al. Among authors: sikirica v. J Manag Care Spec Pharm. 2022 Apr;28(4):426-434. doi: 10.18553/jmcp.2022.28.4.426. J Manag Care Spec Pharm. 2022. PMID: 35332790 Free PMC article.
Mostaghimi reports consulting fees from Pfizer Inc, Concert, Lilly, AbbVie, hims, and Digital Diagnostics; reports equity from Lucid and hims; and is an associate editor at JAMA Dermatology. K. Gandhi, M. Ray, and V. Sikirica are former employees of Pfizer Inc and h …
Mostaghimi reports consulting fees from Pfizer Inc, Concert, Lilly, AbbVie, hims, and Digital Diagnostics; reports equity from Lucid and him …
Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata.
Ray M, Swallow E, Gandhi K, Carley C, Sikirica V, Wang T, Done N, Signorovitch J, Mostaghimi A. Ray M, et al. Among authors: sikirica v. J Health Econ Outcomes Res. 2022 Jul 29;9(2):11-18. doi: 10.36469/001c.36229. eCollection 2022. J Health Econ Outcomes Res. 2022. PMID: 35975139 Free PMC article.
90 results